Scandinavian Biopharma is once again looking back on a very successful business year

Scandinavian Biopharma can look back on a very successful 2019! The company was granted 10.6 MEUR from the EDCTP for a phase III trial of the ETEC vaccine candidate ETVAX® in children in Low- and Middle-Income Countries (LMIC). Impressive clinical results from Phase I/II study in Bangladesh were published. A late phase African paediatric development […]

Welcome Morgan Hjorth

Scandinavian Biopharma continues to expand and strengthen the organization and we are happy to announce that Morgan Hjorth has joined our team. Morgan recently graduate from Karolinska Institute and Royal Institute of Technology (KTH) with two bachelor’s degrees and one Master degree of Science in Medical Biotechnology Engineering. – It feels great to be a […]

Scandinavian Biopharma secures €10.6 million from EDCTP for a Phase III trial of ETVAX® in children in low- and middle-income countries

Scandinavian Biopharma has been awarded a €10.6 million grant from EDCTP in international competition for the planned Phase III clinical trial of the ETEC vaccine candidate ETVAX®. The EDCTP grant is a part of the European Framework Programme for Research and Innovation, Horizon 2020. The project will include the development and manufacturing of an all-in-one […]

Scandinavian Biopharma expands its Nordic vaccine business with the oral typhoid vaccine Vivotif®

Scandinavian Biopharma has entered into a Nordic distribution agreement with Emergent Travel Health for the oral typhoid vaccine Vivotif®. Typhoid fever is a severe and potentially life-threatening infection caused by the Salmonella bacteria. The Scandinavian Biopharma team is very experienced in marketing and sales of vaccines. Since 1st of January 2020 Scandinavian Biopharma is the […]

Christine Källén joins Scandinavian Biopharma as our new VP Quality Assurance

Scandinavian Biopharma has in November appointed Christine Källén as VP Quality Assurance and she will supersede Annette Elmqvist, who is retiring at the end of the year. Christine’s career spans over more than 20 years in quality assurance. Most recently Christine worked at the Swedish Nuclear Fuel and Waste Management Company, SKB, where she was […]



Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.